Our research projects

Having diabetes can lead to damaged blood vessels in the retina at the back of the eye, caused by high blood sugar levels. This can lead to vision problems and sight loss. Dr Judith Lechner wants to find out if a protective protein can be used to repair and reduce this damage, and potentially be used as a new treatment option in the future.

Women with type 1 or type 2 diabetes are at a higher risk of stillbirth and premature birth. Dr Sharon Mackin and her team will analyse national data in Scotland to identify the causes and risk factors for these outcomes. This could lead to better care and decision-making around delivery timing, so that more mothers with diabetes experience a healthy pregnancy and give birth to healthy babies.

People with type 2 diabetes are more likely to develop depression. This could in part be down to our genes. Professor Prokopenko plans to study changes in the GLP-1R gene and look at if, and how, the gene could increase the risk of both type 2 diabetes and depression. If the shared genes affect the development of both conditions it could lead to improved medications that work to treat them. 

Researchers are building AI-powered tools that can identify people most at risk of diabetes complications before they develop. Dr Rebecca Thomas is exploring how people with diabetes feel towards AI being used in this way, and receiving results about their future complications risk. This will inform recommendations on how to communicate AI-driven risk predictions in a way that builds trust and understanding, supporting both physical health and emotional well-being.

Some people develop type 1 diabetes very quickly, but in others, the immune attack that causes type 1 diabetes progresses slowly. Professor Kathleen Gillespie and her PhD student will look for genetic differences between these groups of people to find out why this is. In the future, this could lead to life-changing treatments to delay or prevent type 1 diabetes.

Scientists can grow new insulin-producing beta cells in the lab, but they don’t work as well as ‘real’ beta cells. Dr Ildem Akerman will test out a new way to improve how we make lab-grown beta cells, she hopes this will make them work better and be more responsive to changes in blood sugar. In the future, we hope lab-grown beta cells could be transplanted into people with type 1 or type 2 diabetes to replace the cells that have been destroyed or stopped working, and this project could help us take a huge step towards that goal.

Muscle damage is a common but under-studied complication of type 2 diabetes. It reduces mobility and can affect independence. Professor Lee Roberts will explore if a drug licensed to treat problems with how the body processes iron could help to improve muscle health and quality of life. This could improve our understanding of muscle damage in people with type 2 diabetes and provide us with better ways to treat it.

Polypharmacy is when people are prescribed multiple medications at the same time. It’s common in people with diabetes, and while it can be helpful in many ways, it can also throw up challenges. Professor David McAllister wants to shed more light on polypharmacy in people with diabetes. He’ll study health records and interview people with diabetes and healthcare professionals to understand their experiences. This clearer picture could help to develop approaches to reduce polypharmacy and its harm. 

Studies in labs show that breaking up sitting time could help people with type 1 diabetes lower their blood sugar levels. Dr Katie Hesketh and her team will test this with people in their day-to-day lives for the first time. This could give people with type 1 diabetes a simple and practical way to manage their condition and lower their risk of developing complications. 

People living with insulin resistance can help to manage their blood sugar levels by making healthier food choices. But a hormone called oxytocin has been found to play a part in the foods we tend to prefer. Dr John Menzies wants to find out more about the link between oxytocin and insulin resistance. Understanding how different hormone levels change in diabetes will help researchers to develop new treatments helping people to make healthier food choices.